With over 2 year's experience in finance and the crypto sectors, Jose uses his knowledge and expertise to breakdown complex topics into bitesize content for both beginners and experts.
With the crypto market shifting its sentiment towards the bull side, many tokens are seeing gains. On the other hand, some still face uncertainty. Injective Protocol ($INJ) is catching the public’s attention with predictions that it could reach $20.
Meanwhile, Aave Founder Stani Kulechov’s recent sale of $6.7 million worth of $AAVE tokens during a price surge has sparked discussions in the market.
However, Injective and Aave are not the only projects that are making headlines; BlockDAG is one of the projects that also snuck into the limelight. Following its high-profile partnerships with Borussia Dortmund and Inter Milan, rumors are swirling that BlockDAG is now targeting a deal with a Premier League club in England. Combined with its presale success, where the project raised over $74.5 million in just a few months, this momentum is pushing BlockDAG closer to potentially reaching the $1 mark.
Injective Protocol ($INJ) has been on an upward trend, with its price hovering around $12. According to Changelly’s $INJ price prediction, the token could break through the $20 barrier by the end of 2024, driven by the growth of the broader DeFi sector.
However, reaching this milestone will depend on various factors, including market adoption and platform developments. If market conditions align, Injective could exceed its previous highs, solidifying its place in the DeFi space.
In other news, Aave’s founder, Stani Kulechov, recently sold $6.7 million worth of $AAVE tokens, raising eyebrows in the crypto community. This sale coincided with a significant
Read more on cryptonews.com